Your Best Stock
Stocks › HCA

HCA Healthcare HCA

US equityMarket cap rank #171
$428.24
−$8.24 (-1.89%)
Market open · Sep 24, 2:00 pm ET
After hours $436.48 0.00%
Open$438.25
Prev close$436.48
Day range$428.02 – $442.21
Volume378.5K
Market cap$92.71B
P/E (TTM)14.4
Dividend yield0.70%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$20.23B+8.7% YoY
Operating profit$3.07B+3.4% YoY
Net profit$1.93B+2.1% YoY
Diluted EPS$7.62+11.6% YoY
Free cash flow$1.10B-63.6% YoY
Operating cash flow$2.34B

Revenue, last 8 quarters

$17.5BSep '24$18.3BDec '24$18.3BMar '25$18.6BJun '25$19.2BSep '25$19.5BDec '25$19.1BMar '26$20.2BJun '26

Net profit, last 8 quarters

$1.5BSep '24$1.7BDec '24$1.8BMar '25$1.9BJun '25$1.9BSep '25$2.2BDec '25$1.9BMar '26$1.9BJun '26

Diluted EPS by quarter

4.88Sep '245.63Dec '246.45Mar '256.83Jun '256.96Sep '258.14Dec '257.15Mar '267.62Jun '26

Free cash flow by quarter

$2.3BSep '24$1.3BDec '24$660.0MMar '25$3.0BJun '25$3.1BSep '25$870.0MDec '25$895.0MMar '26$1.1BJun '26

Annual revenue

$51.5BFY20$58.8BFY21$60.2BFY22$65.0BFY23$70.6BFY24$75.6BFY25

Profitability & balance sheet

Gross margin42.6%
Operating margin15.5%
Net margin8.8%
Return on assets11.1%
Current ratio0.99
Liabilities / assets105.1%
Cash & investments$1.01B
Total debt$51.55B
Net cash (debt)-$50.54B
Free cash flow / sales7.7%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $20.23B $19.11B $75.60B $19.51B $19.16B
Total Operating Revenue $20.23B $19.11B $75.60B $19.51B $19.16B
Cost of Revenue $11.18B $11.14B $44.23B $11.34B $11.15B
Gross Profit $9.05B $7.97B $31.37B $8.18B $8.02B
Operating Expense $5.99B $5.11B $19.41B $5.00B $5.05B
Depreciation & Amortization & Depletion $944.00M $930.00M $3.52B $911.00M $889.00M
-Depreciation & Amortization $944.00M $930.00M $3.52B $911.00M $889.00M
Other Operating Expenses $5.04B $4.18B $15.89B $4.09B $4.16B
Operating Profit $3.07B $2.86B $11.97B $3.18B $2.97B
Net Non-Operating Interest Income (Expense) -$599.00M -$584.00M -$2.25B -$572.00M -$561.00M
Non-Operating Interest Expense $599.00M $584.00M $2.25B $572.00M $561.00M
Other Income (Expense) $26.00M $8.00M $115.00M $66.00M $14.00M
Earnings from Equity Interest $16.00M $9.00M $78.00M $25.00M $16.00M
Special Income (Charges) $10.00M -$1.00M $37.00M $41.00M -$2.00M
-Gain on Sale Of Business $10.00M -$1.00M $37.00M $41.00M -$2.00M
Pretax Profit $2.49B $2.29B $9.83B $2.67B $2.42B
Tax $564.00M $430.00M $2.05B $509.00M $515.00M
Net Profit $1.93B $1.86B $7.78B $2.16B $1.90B
Profit from Continuing Operations $1.93B $1.86B $7.78B $2.16B $1.90B
Minority Interests $231.00M $237.00M $998.00M $285.00M $260.00M
Net Income to Parent Company $1.70B $1.62B $6.78B $1.88B $1.64B
Net Income to Common Stockholders $1.70B $1.62B $6.78B $1.88B $1.64B
Basic EPS $7.70 $7.25 $28.70 $8.36 $7.05
Diluted EPS $7.62 $7.15 $28.33 $8.14 $6.96
Dividend Per Share $0.78 $0.78 $2.88 $0.72 $0.72

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $63.25B $61.45B $60.72B $60.72B $59.75B
Total Current Assets $17.19B $16.05B $15.78B $15.78B $15.29B
Cash and Cash Equivalents & Short-Term Investments $1.01B $940.00M $1.04B $1.04B $997.00M
-Cash and Cash Equivalents $1.01B $940.00M $1.04B $1.04B $997.00M
Receivables $12.28B $11.32B $10.87B $10.87B $10.43B
-Accounts Receivable $12.28B $11.32B $10.87B $10.87B $10.43B
Inventory $1.66B $1.68B $1.65B $1.65B $1.73B
Other Current Assets $2.23B $2.11B $2.22B $2.22B $2.13B
Total Non-Current Assets $46.06B $45.40B $44.94B $44.94B $44.46B
Net PPE $33.93B $33.57B $33.27B $33.27B $32.68B
-Gross PPE $70.52B $69.46B $68.41B $68.41B $67.60B
-Accumulated Depreciation -$36.59B -$35.89B -$35.13B -$35.13B -$34.92B
Investments and Advances $1.22B $1.00B $1.12B $1.12B $1.23B
-Long Term Equity Investment $1.22B $1.00B $1.12B $1.12B $1.23B
Goodwill and Other Intangible Assets $10.66B $10.50B $10.29B $10.29B $10.28B
Other Non-Current Assets $258.00M $326.00M $255.00M $255.00M $277.00M
Total Liabilities $66.46B $64.43B $63.49B $63.49B $61.91B
Total Current Liabilities $17.31B $19.26B $16.35B $16.35B $17.90B
Payables $4.75B $4.81B $5.16B $5.16B $4.55B
-Accounts Payable $4.75B $4.81B $4.66B $4.66B $4.55B
Current Accrued Expenses $6.30B $5.92B $4.97B $4.97B $7.23B
Short-Term Debt and Capital Lease Obligation $6.26B $8.53B $5.24B $5.24B $6.11B
-Current Debt $6.26B $8.53B $4.89B $4.89B $6.11B
Total Non-Current Liabilities $49.15B $45.17B $47.14B $47.14B $44.01B
Long Term Debt and Capital Lease Obligation $45.29B $41.31B $43.46B $43.46B $40.24B
-Long Term Debt $43.45B $39.49B $41.60B $41.60B $38.40B
-Long Term Capital Lease Obligation $1.83B $1.82B $1.85B $1.85B $1.84B
Other Non-Current Liabilities $3.86B $3.86B $3.69B $3.69B $3.77B
Total Equity -$3.21B -$2.98B -$2.77B -$2.77B -$2.16B
Stockholders' Equity -$6.64B -$6.30B -$6.03B -$6.03B -$5.34B
Capital Stock $2.00M $2.00M $2.00M $2.00M $2.00M
-Common Stock $2.00M $2.00M $2.00M $2.00M $2.00M
Retained Earnings -$6.31B -$5.98B -$5.72B -$5.72B -$5.02B
Gains/Losses Not Affecting Retained Earnings -$334.00M -$327.00M -$305.00M -$305.00M -$317.00M
Minority Interests $3.43B $3.33B $3.26B $3.26B $3.18B
-Total Tax Payable – – $504.00M $504.00M –
-Current Capital Lease Obligation – – $352.00M $352.00M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $2.34B $2.01B $12.64B $2.36B $4.42B
Net cash flow from continuing operations $2.34B $2.01B $12.64B $2.36B $4.42B
Net Income from Continuing Operations $1.93B $1.86B $7.78B $2.16B $1.90B
Gain/Loss from Continuing Operations -$10.00M $1.00M -$37.00M -$41.00M $2.00M
Depreciation & Depletion & Amortization $944.00M $930.00M $3.52B $911.00M $889.00M
Deferred Tax -$166.00M $435.00M $310.00M -$1.00B $434.00M
Other Non-Cash Items $61.00M $78.00M $239.00M $61.00M $52.00M
Change in Working Capital -$509.00M -$1.37B $418.00M $169.00M $1.03B
-Change in Receivables -$954.00M -$463.00M -$94.00M -$439.00M $25.00M
-Change in Inventory -$106.00M $80.00M -$154.00M -$29.00M $302.00M
-Change in Payables and Accrued Expense $551.00M -$990.00M $666.00M $637.00M $705.00M
Net cash flow from investing -$1.56B -$1.28B -$4.99B -$1.32B -$1.39B
Net Cash Flow from Continuing Investing Activities -$1.56B -$1.28B -$4.99B -$1.32B -$1.39B
Net PPE Purchase and Sale -$1.23B -$1.12B -$4.94B -$1.49B -$1.29B
Net Business Purchase and Sale -$103.00M -$262.00M -$128.00M $56.00M -$25.00M
Net Investment Purchase and Sale -$223.00M $103.00M $72.00M $98.00M -$67.00M
Net Other Investing Changes $0.00 -$4.00M $12.00M $18.00M -$8.00M
Financing Cash Flow -$704.00M -$830.00M -$8.55B -$999.00M -$2.97B
Net Cash Flow from Continuing Financing Activities -$704.00M -$830.00M -$8.55B -$999.00M -$2.97B
Net Issuance Payments Of Debt $1.69B $1.38B $3.29B $1.98B -$36.00M
Net Common Stock Issuance -$2.06B -$1.57B -$10.07B -$2.56B -$2.50B
Cash Dividends Paid -$171.00M -$183.00M -$679.00M -$162.00M -$166.00M
Net Other Financing Charges -$157.00M -$453.00M -$1.09B -$261.00M -$267.00M
Ending Cash Balance $1.01B $940.00M $1.04B $1.04B $997.00M
Net Change in Cash $74.00M -$98.00M -$902.00M $43.00M $61.00M
Beginning Cash Balance $940.00M $1.04B $1.93B $997.00M $939.00M
Effect of Exchange Rate Changes -$1.00M -$2.00M $9.00M $0.00 -$3.00M
Free Cash Flow $1.10B $895.00M $7.69B $870.00M $3.13B
Scroll to Top